Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.

NCT04086095 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04086095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04086095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
May 13, 2019
Completion date
October 31, 2019
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome in premature infant, surfactant deficiency syndrome neonatal